Health Net Cost Control Strategies (cont.)
Moving to 4-tier Rx benefit
- Offers greater flexibility
- Benefit buy-downs in our product portfolio allow Health Net to offer competitively priced products
- Tier assignment driven by unit cost and clinical utility
- Minimizing potential negative impact on rebates
- No more lock-in or narrow definitions
- Brand vs. generic
- Formulary vs. non-formulary
- Hedge against drugs coming off patent and high-cost generics
- Ability to address
- Lifestyle and pipeline medications and self-injectables